Instead of overshadowing the drug pricing debate, the coronavirus outbreak is adding urgency to it. A win on drug pricing would help the president recover from criticism of his handling of the emerging threat, and the potential strain on the health care system could underscore the need for drug-pricing reforms. President Donald Trump tweeted over the weekend that he will meet with drug companies Monday (March 2) to discuss the status of vaccines and treatments for the 2019 novel coronavirus...